BioVie Inc. (BIVI)
BIVI Stock Price Chart
Explore BioVie Inc. interactive price chart. Choose custom timeframes to analyze BIVI price movements and trends.
BIVI Company Profile
Discover essential business fundamentals and corporate details for BioVie Inc. (BIVI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Sept 2020
Employees
14.00
Website
https://bioviepharma.comCEO
Cuong Viet Do
Description
BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also in a Phase I clinical trial for the treatment of Parkinson's disease. Further preclinical investigations are underway for NE3107, exploring its potential applications in treating multiple myeloma and prostate cancer. Established in 2013, the company adopted its current name, BioVie Inc., in July 2016, having previously operated as NanoAntibiotics, Inc. Its corporate headquarters are situated in Carson City, Nevada.
BIVI Financial Timeline
Browse a chronological timeline of BioVie Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.52.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.52.
Earnings released on 11 May 2026
EPS came in at -$0.70 surpassing the estimated -$0.73 by +4.11%.
Earnings released on 6 Feb 2026
EPS came in at -$0.77 surpassing the estimated -$0.81 by +4.94%.
Earnings released on 10 Nov 2025
EPS came in at -$0.98 falling short of the estimated -$0.79 by -24.05%.
Earnings released on 15 Aug 2025
EPS came in at -$0.24 surpassing the estimated -$4.40 by +94.63%.
Stock split effective on 7 Jul 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 May 2025
EPS came in at -$1.50 surpassing the estimated -$3.20 by +53.13%.
Earnings released on 11 Feb 2025
EPS came in at -$4.60 surpassing the estimated -$16.00 by +71.25%.
Earnings released on 13 Nov 2024
EPS came in at -$7.00 surpassing the estimated -$16.00 by +56.25%.
Earnings released on 30 Sept 2024
EPS came in at -$66.00 falling short of the estimated -$15.00 by -340.00%.
Stock split effective on 6 Aug 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 May 2024
EPS came in at -$20.00 falling short of the estimated -$0.33 by -5.96k%.
Earnings released on 12 Feb 2024
EPS came in at -$22.00 surpassing the estimated -$32.00 by +31.25%.
Earnings released on 8 Nov 2023
EPS came in at -$29.00 falling short of the estimated -$0.31 by -9.25k%.
Earnings released on 16 Aug 2023
EPS came in at -$23.00 surpassing the estimated -$37.00 by +37.84%.
Earnings released on 12 May 2023
EPS came in at -$43.00 falling short of the estimated -$0.35 by -12.19k%.
Earnings released on 10 Feb 2023
EPS came in at -$50.00 falling short of the estimated -$0.25 by -19.90k%.
Earnings released on 4 Nov 2022
EPS came in at -$38.00 falling short of the estimated -$0.28 by -13.47k%.
Earnings released on 27 Sept 2022
EPS came in at -$33.00 falling short of the estimated -$0.37 by -8.82k%.
Earnings released on 11 May 2022
EPS came in at -$0.28 surpassing the estimated -$0.42 by +33.33%.
Earnings released on 8 Feb 2022
EPS came in at -$0.28 surpassing the estimated -$0.31 by +9.68%.
Earnings released on 10 Nov 2021
EPS came in at -$23.36 .
Earnings released on 30 Aug 2021
EPS came in at -$10.18 falling short of the estimated -$2.32 by -338.79%.
BIVI Stock Performance
Access detailed BIVI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
